Maternal Subclinical Hyperthyroidism and Adverse Pregnancy Outcomes: A Systematic Review and Meta-analysis of Observational Studies
International Journal of Endocrinology and Metabolism · 19.07.2022 · 20 (3)
DOI: 10.5812/ijem-120949 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift International Journal of Endocrinology and Metabolism, online erschienen am 19.07.2022. Verfasst von Sima Nazarpour und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Midwifery, Varamin-Pishva Branch, Islamic Azad University, Tehran, Iran. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Context
Findings from studies evaluating adverse pregnancy outcomes in pregnant women with subclinical hyperthyroidism are conflicting and inconclusive.
Objectives
In this systematic review and meta-analysis, our aim was to evaluate the pooled odds ratio (OR) of adverse pregnancy outcomes in women with subclinical hyperthyroidism, compared to euthyroid women. Data Sources: Scopus, PubMed (including Medline), and Web of Science databases were systemically searched for regaining published studies to January 2022 examining adverse pregnancy outcomes in women with subclinical hyperthyroidism. Study Selection: Outcomes of interest were classified into seven composite outcomes, including hypertensive disorders, preterm delivery, macrosomia/large for gestational age (LGA), pregnancy loss, adverse maternal outcomes, adverse neonatal outcomes, and adverse fetal outcomes. Data Extraction: In this meta-analysis, both fixed and random effect models were used. Publication bias was also evaluated by Egger test and the funnel plot, and the trim and fill method was conducted in case of a significant result, to adjust the bias.
Results
Of 202 records retrieved through searching databases, 11 studies were selected for the final analyses. There were no significant differences in pooled ORs of hypertensive disorders, preterm delivery, macrosomia/LGA, and pregnancy loss in pregnant women with subclinical hyperthyroidism, compared to the euthyroid controls. The pooled OR of adverse maternal, neonatal, and fetal outcomes in pregnant women with subclinical hyperthyroidism was not statistically significantly different from that of the euthyroid control group.
Conclusions
The current meta-analysis demonstrated that subclinical hyperthyroidism in pregnancy is not related with adverse maternal and fetal outcomes. Therefore, clinicians should be avoided unnecessary treatments for pregnant women with subclinical hyperthyroidism.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Midwifery, Varamin-Pishva Branch, Islamic Azad University, Tehran, Iran.
- Reproductive Endocrinology Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
- Department of Biostatistics, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.
- Endocrine Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
ORCID-Profile: Sima Nazarpour, Fahimeh Ramezani Tehrani
Zitieren
APA
Nazarpour, S., Amiri, M., Bidhendi Yarandi, R., Azizi, F., & Ramezani Tehrani, F. (2022). Maternal Subclinical Hyperthyroidism and Adverse Pregnancy Outcomes: A Systematic Review and Meta-analysis of Observational Studies. International Journal of Endocrinology and Metabolism, 20(3). https://doi.org/10.5812/ijem-120949
Vancouver
Nazarpour S, Amiri M, Bidhendi Yarandi R, Azizi F, Ramezani Tehrani F. Maternal Subclinical Hyperthyroidism and Adverse Pregnancy Outcomes: A Systematic Review and Meta-analysis of Observational Studies. International Journal of Endocrinology and Metabolism. 2022;20(3). doi:10.5812/ijem-120949
BibTeX
@article{Nazarpour2022,
author = {Nazarpour, Sima and Amiri, Mina and Bidhendi Yarandi, Razieh and Azizi, Fereidoun and Ramezani Tehrani, Fahimeh},
title = {Maternal Subclinical Hyperthyroidism and Adverse Pregnancy Outcomes: A Systematic Review and Meta-analysis of Observational Studies},
journal = {International Journal of Endocrinology and Metabolism},
year = {2022},
volume = {20},
number = {3},
doi = {10.5812/ijem-120949}
}
EUVIMED